Green Thumb Industries Inc. (GTBIF) Stock Price & Analysis
Green Thumb Industries Inc. (GTBIF) fell 1.40% to USD 7.02 as of July 25, 2026 at 04:57 UTC, according to Nexqual real-time market data.
GTBIF last closed at USD 7.12; the session ranged USD 6.97–7.16 on volume of 100,759 shares. Market capitalization is $1.54B, with a 52-week range of USD 5.29–10.43 (OQX). Source: Nexqual, July 25, 2026 at 04:57 UTC.
Key Statistics (as of July 25, 2026 at 04:57 UTC)
| Price | USD 7.02 |
|---|---|
| Change | ▼ 1.40% (down) |
| Previous Close | USD 7.12 |
| Open | USD 7.05 |
| Day Range | USD 6.97 – 7.16 |
| 52-Week Range | USD 5.29 – 10.43 |
| Volume | 100,759 shares |
| Market Cap | $1.54B |
| Exchange | OQX |
Technical Analysis (GTBIF)
Nexqual's technical model rates GTBIF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:57 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.2 (neutral) |
| vs SMA50 | Below (USD 7.55) |
| MACD | -0.15 (negative) |
Analyst Ratings (GTBIF)
Wall Street analysts rate GTBIF "Strong Buy" based on 3 analysts, with a mean price target of USD 15.67 (range USD 10–20), per Nexqual as of July 25, 2026 at 04:57 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 15.67 |
| High Target | USD 20 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 8 / 0 / 0 |
Earnings (GTBIF)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD -0.01 |
| Revenue Estimate | $298.95M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.04 vs est -0.02 ▲ beat |
| 2025-12-31 | USD 0.03 vs est -0.01 ▲ beat |
| 2025-09-30 | USD 0.1 vs est 0.04 ▲ beat |
| 2025-06-30 | USD 0.05 vs est 0.03 ▲ beat |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Financials & Fundamentals (GTBIF)
| Total Revenue | $1.20B |
|---|---|
| Revenue Growth (YoY) | +7.40% |
| Gross Margin | +48.10% |
| Operating Margin | +13.57% |
| Profit Margin | +10.14% |
| ROE | +6.63% |
| Debt / Equity | 29.64 |
| Current Ratio | 3.47 |
| Total Cash | $344.51M |
| Total Debt | $562.37M |
| Free Cash Flow | $146.94M |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Financial Health Score (GTBIF)
Nexqual rates Green Thumb Industries Inc.'s overall financial health "Solid" across five dimensions, as of July 25, 2026 at 04:57 UTC.
| Growth | Mixed — Revenue +3.4% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 48%, operating 14% |
| Balance Sheet | Strong — $345M cash vs $562M debt |
| Cash Flow | Solid — FCF $147M, 13% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.1% |
Ownership (GTBIF)
| Insider Ownership | +1.89% |
|---|---|
| Institutional Ownership | +8.18% |
| Shares Outstanding | 195.07M |
| Float | 190.60M |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Leadership (GTBIF)
Green Thumb Industries Inc. is led by Benjamin Kovler (age 46), Founder, Chairman & CEO, per Nexqual as of July 25, 2026 at 04:57 UTC.
| Founder, Chairman & CEO | Benjamin Kovler (age 46) |
|---|---|
| President & Director | Anthony Georgiadis (age 47) |
| Chief Financial Officer | Mathew Faulkner (age 51) |
| President of Operations | Matt Navarro |
| Senior Vice President of Technology | Josh Barrington |
From Green Thumb Industries Inc.'s Latest SEC 10-K Filing (filed 2026-02-25)
Key Strengths & Strategy (as disclosed to the SEC)
- The Company also licenses certain intellectual property to and from third parties for the manufacture and sale of consumer products.   As the Company became licensed to cultivate cannabis, we have developed proprietary cultivation techniques.
- Adult-use cannabis became legal in Massachusetts as of December 15, 2016, following a ballot initiative in November 2016.   Massachusetts Licenses and Regulations   There is one principal medical cannabis license category in Massachusetts: a vertically integrated Medical Marijuana Treatment Center ("MTC") license.
- License types in New Jersey include vertically integrated medical Alternative Treatment Centers and medical or adult-use cultivator, dispensary, and manufacturer licenses.   We are licensed to operate two adult-use/medical cultivation facilities, one of which is co-located with a processing facility, one retail medical cannabis dispensary and two retail adult-use/medical dispensaries in the state of New Jersey.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TRLV | Trulieve Cannabis Corp. Subordi | USD 8.36 | ▼ 3.58% |
| CRLBF | Cresco Labs Inc. | USD 0.68 | ▼ 4.35% |
| GRWG | GrowGeneration Corp. | USD 1.38 | ▲ 0% |
| IIPR | Innovative Industrial Propertie | USD 61.48 | ▼ 1.33% |
| CWBHF | Charlotte's Web Holdings Inc. | USD 0.24 | ▲ 8.11% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:57 UTC. This page is informational and not investment advice.